Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy

BACKGROUND: Current evidence suggests that rivaroxaban may be well tolerated and effective in patients with nonvalvular atrial fibrillation (NVAF) and obesity; however, there is limited evidence on the impact of polypharmacy in this population. This study evaluated real-world clinical outcomes with...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberts, Mark J., He, Jinghua, Kharat, Akshay, Ashton, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270287/
https://www.ncbi.nlm.nih.gov/pubmed/35092000
http://dx.doi.org/10.1007/s40256-021-00520-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270287/
https://www.ncbi.nlm.nih.gov/pubmed/35092000
http://dx.doi.org/10.1007/s40256-021-00520-7

Ejemplares similares